← Eichor
Study identifier: NCT05573997 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure

Condition: Cardiovascular Diseases · Heart Failure · Valvular Heart Disease  ·  Sponsor: Aristotle University Of Thessaloniki

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study seeks to investigate the clinical value of novel echocardiographic indices, including myocardial work parameters, during the acute phase of heart failure hospitalization. The trajectory of novel echocardiographic indices from the start to the end of hospitalization will be captured, as a means to unravel and subsequently better understand the diverse pathophysiology of different phenotypes of the heart failure continuum. Correlation between novel echocardiographic indices with clinical data, biochemical data, different heart failure phenotypes, and therapeutic maneuvers will be attempted. Prognostic implications of those indices will be explored.

This description comes directly from the study's public registry record.

Talk to the study team

Stylianos Daios, MD, MSc  ·  6947529606  ·  stylianoschrys.daios@gmail.com

Vasileios Anastasiou, MD, MSc  ·  6978223907  ·  vasianas44@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

AHEPA University Hospital, Thessaloniki, GreeceThessaloniki, Central Macedonia, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05573997